Harrow Health Langfristiger Schuldenstrom 2011-2026 | HROW

Langfristiger Schuldenstrom Jährlich Harrow Health

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998
887 K	497 K	806 K	723 K	272 K	580 K	629 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
887 K	272 K	628 K

Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller

Name	Langfristiger Schuldenstrom	Preis	% 24h	Marktkapitalisierung	Land
Cumberland Pharmaceuticals CPIX	468 K	$ 5.87	6.53 %	$ 87.2 M	USA
Endo International plc ENDP	956 K	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	59.5 K	-	-	$ 36.6 M	USA
HEXO Corp. HEXO	914 K	-	2.45 %	$ 38.1 M	Canada
Calliditas Therapeutics AB (publ) CALT	12.5 M	-	-0.1 %	$ 2.03 B	Schweden
AcelRx Pharmaceuticals ACRX	100 K	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	1.08 M	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	343 K	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	4.36 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	366 K	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	634 K	-	-	$ 142 M	USA
Cronos Group CRON	337 K	$ 2.74	0.37 %	$ 1.05 B	Canada
Athenex ATNX	2.09 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	582 K	-	-	$ 2.06 B	France
Catalent CTLT	13 M	-	-	$ 11.5 B	USA
Organogenesis Holdings ORGO	4.95 M	$ 2.66	-	$ 337 M	USA
Pacira BioSciences PCRX	8.89 M	$ 23.35	-0.55 %	$ 1.08 B	USA
Eagle Pharmaceuticals EGRX	1.53 M	-	-39.89 %	$ 27.7 M	USA
Bausch Health Companies BHC	61 M	$ 5.47	0.37 %	$ 2 B	Canada
Canopy Growth Corporation CGC	7.46 M	$ 1.04	-2.8 %	$ 112 M	Canada
Tilray TLRY	2.47 M	$ 5.29	-3.11 %	$ 3.27 B	Canada
Solid Biosciences SLDB	2.1 M	$ 6.62	1.85 %	$ 579 M	USA
Aurora Cannabis ACB	5.38 M	$ 3.46	-2.81 %	$ 190 M	Canada
Sonoma Pharmaceuticals SNOA	58 K	$ 1.1	3.77 %	$ 1.37 M	USA
Jupiter Wellness JUPW	23.5 K	-	-	$ 33.6 M	USA
Lannett Company LCI	2.06 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	1.03 M	$ 1.12	-0.88 %	$ 107 M	Canada
Evolus EOLS	2.53 M	$ 6.09	-5.58 %	$ 393 M	USA
Sundial Growers SNDL	35.5 M	$ 1.45	-1.36 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	2.4 M	$ 8.45	0.96 %	$ 433 M	USA
Veru VERU	759 K	$ 2.35	5.86 %	$ 34.4 M	USA
Neoleukin Therapeutics NLTX	3.05 M	-	-	$ 193 M	Canada
cbdMD YCBD	778 K	$ 0.76	-2.32 %	$ 3.06 M	USA
Assertio Holdings ASRT	240 K	$ 23.44	0.3 %	$ 150 M	USA
ProPhase Labs PRPH	301 K	-	-	$ 5.07 M	USA
Radius Health RDUS	613 K	-	-	$ 1.42 B	USA
PetIQ PETQ	7.61 M	-	1.64 %	$ 400 M	USA
Recro Pharma REPH	1.1 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	911 K	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	483 K	$ 0.73	3.0 %	$ 36.5 M	USA
PLx Pharma PLXP	622 K	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	109 M	$ 16.65	1.15 %	$ 19.4 B	USA
Zomedica Corp. ZOM	717 K	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	215 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	1.16 M	$ 0.79	-2.06 %	$ 28.4 M	USA
Tricida TCDA	2.74 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	71.6 K	$ 0.76	-0.29 %	$ 3.26 M	China
TherapeuticsMD TXMD	975 K	$ 2.12	0.47 %	$ 24.5 M	USA